Omid Farokhzad
Chief Executive Officer at SEER, INC.
Net worth: 10 M $ as of 2024-03-30
Profile
Founder of 5 different companies, among them: Seer, Inc. (California), Selecta Biosciences, Inc. and DNIB Unwind, Inc. Omid C. Farokhzad is an entrepreneur and is Chairman & Chief Executive Officer for Seer, Inc. (California) (which he founded in 2017). He is also on the board of Placon Therapeutics, Inc. In his past career he was Chairman for Selecta Biosciences, Inc. (he founded the company in 2007), Associate Professor at Harvard Medical School, Director at DNIB Unwind, Inc. and Director at Tarveda Therapeutics, Inc. Dr. Farokhzad received a doctorate and a graduate degree from Boston University School of Medicine and an MBA from Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SEER, INC.
87.67% | 2023-12-30 | 3,555,195 ( 87.67% ) | 7 M $ | 2024-03-30 |
SEER, INC. CLASS A
2.37% | 2024-03-06 | 1,436,285 ( 2.37% ) | 3 M $ | 2024-03-30 |
SENTI BIOSCIENCES, INC.
4.26% | 2023-06-15 | 1,947,403 ( 4.26% ) | 734 171 $ | 2024-03-30 |
Omid Farokhzad active positions
| Companies | Position | Start |
|---|---|---|
| SEER, INC. | Chief Executive Officer | 2018-02-28 |
| SENTI BIOSCIENCES, INC. | Director/Board Member | 2022-06-07 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Director/Board Member | - |
| Xlink Therapeutics, Inc. | Founder | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Founder | - |
| Xira Connect, Inc. | Director/Board Member | 2019-07-31 |
Former positions of Omid Farokhzad
| Companies | Position | End |
|---|---|---|
| DYNC SPL | Chairman | 2022-05-31 |
| CARTESIAN THERAPEUTICS, INC. | Founder | 2019-11-18 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Founder | 2018-12-31 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Omid Farokhzad
| MIT Sloan School of Management | Masters Business Admin |
| Boston University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SEER, INC. | Health Technology |
| Private companies | 11 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The private company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Dynamics Special Purpose Corp. is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded on March 1, 2021 and is headquartered in Redwood City, CA. | Finance |
| Xlink Therapeutics, Inc. | |
| Xira Connect, Inc. | |
| Senti Biosciences, Inc. |
- Stock Market
- Insiders
- Omid Farokhzad
